BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1042 related articles for article (PubMed ID: 16153928)

  • 1. Eight-year results after aortic valve replacement with the CryoLife-O'Brien Stentless Aortic Porcine Bioprosthesis.
    Martinovic I; Farah I; Everlien M; Lindemann S; Knez I; Wittlinger T; Greve H; Vogt P
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):777-82. PubMed ID: 16153928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midterm results after aortic valve replacement with a stentless bioprosthesis aortic valve.
    Martinovic I; Everlien M; Farah I; Wittlinger T; Knez I; Greve H; Vogt P
    Ann Thorac Surg; 2005 Jul; 80(1):198-203. PubMed ID: 15975367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aortic valve replacement with the Cryolife-O'Brien stentless aortic bioprosthesis: five-year experience.
    Martinovic I; Farah I; Everlien M; Knez I; Greve HP; Vogt P
    J Cardiovasc Surg (Torino); 2004 Dec; 45(6):557-63. PubMed ID: 15746635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with stentless aortic xenografts.
    Luciani GB; Auriemma S; Casali G; Barozzi L; Lamascese N; Mazzucco A
    J Heart Valve Dis; 2000 Nov; 9(6):794-800. PubMed ID: 11128787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aortic valve replacement with a Cryolife O'Brien stentless bioprosthesis].
    Campos V; Adrio B; Estévez F; Mosquera VX; Pérez J; Cuenca JJ; Herrera JM; Valle JV; Portela F; Rodríguez F; Juffé A
    Rev Esp Cardiol; 2007 Jan; 60(1):45-50. PubMed ID: 17288955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Stentless Cryo-Life O'Brien porcine aortic valve at 10 years.
    Hvass U; Baron F; Elsebaey A; Nguyen D; Flecher E
    J Heart Valve Dis; 2004 Nov; 13(6):977-83; discussion 983. PubMed ID: 15597593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic valve replacement with stentless porcine aortic valves: a ten-year experience.
    David TE; Feindel CM; Scully HE; Bos J; Rakowski H
    J Heart Valve Dis; 1998 May; 7(3):250-4. PubMed ID: 9651835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of the Cryolife O'Brien and Toronto stentless replacement aortic valves.
    Chambers JB; Rimington HM; Rajani R; Hodson F; Shabbo F
    J Thorac Cardiovasc Surg; 2007 Apr; 133(4):1045-50. PubMed ID: 17382651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited long-term durability of the Cryolife O'Brien stentless porcine xenograft valve.
    Pavoni D; Badano LP; Ius F; Mazzaro E; Frassani R; Gelsomino S; Livi U
    Circulation; 2007 Sep; 116(11 Suppl):I307-13. PubMed ID: 17846322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular mass regression after aortic valve replacement with CryoLife-O'Brien stentless aortic bioprosthesis.
    Gelsomino S; Frassani R; Morocutti G; Porreca L; Tursi V; Masullo G; Lumini R; Livi U
    J Heart Valve Dis; 2001 Sep; 10(5):603-10. PubMed ID: 11603600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of aortic valve replacement with the St. Jude Toronto stentless porcine valve.
    Desai ND; Merin O; Cohen GN; Herman J; Mobilos S; Sever JY; Fremes SE; Goldman BS; Christakis GT
    Ann Thorac Surg; 2004 Dec; 78(6):2076-83; discussion 2076-83. PubMed ID: 15561040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic valve replacement with the Sorin Pericarbon Freedom stentless valve: five-year follow up.
    Nyawo B; Graham R; Hunter S
    J Heart Valve Dis; 2007 Jan; 16(1):42-8. PubMed ID: 17315382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CryoLife-O'Brien stentless valve: 10-year results of 402 implants.
    O'Brien MF; Gardner MA; Garlick B; Jalali H; Gordon JA; Whitehouse SL; Strugnell WE; Slaughter R
    Ann Thorac Surg; 2005 Mar; 79(3):757-66. PubMed ID: 15734372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results with the Biocor-SJM stentless porcine aortic bioprosthesis.
    Vrandecic M; Fantini FA; Filho BG; de O; da C; Vrandecic E
    J Heart Valve Dis; 2002 Jan; 11(1):47-53. PubMed ID: 11843505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stentless aortic xenograft valve replacement: lessons learned after 300 implants.
    Luciani GB; Bertolini P; Vecchi B; Barozzi L; Casali G; Mazzucco A
    Semin Thorac Cardiovasc Surg; 1999 Oct; 11(4 Suppl 1):139-44. PubMed ID: 10660182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porcine or human stentless valves for aortic valve replacement? Results of a 10-year comparative study.
    Ali A; Lim E; Halstead J; Ashrafian H; Ali Z; Khalpey Z; Theodorou P; Chamageorgakis T; Kumar P; Jackson C; Pepper J
    J Heart Valve Dis; 2003 Jul; 12(4):430-5; discussion 435. PubMed ID: 12918841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients.
    D'Onofrio A; Auriemma S; Magagna P; Favaro A; Cannarella A; Piccin C; Bilotta M; Abbiate N; Lamascese N; Fabbri A
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):491-5. PubMed ID: 17662795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of a simplified technique for aortic valve replacement with stentless bioprostheses.
    Di Matteo G; Masala N; Swanevelder J; Davies J; Galiñanes M; Sosnowski AW
    J Heart Valve Dis; 2009 Jan; 18(1):111-8. PubMed ID: 19301562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Freedom SOLO valve for aortic valve replacement: clinical and hemodynamic results from a prospective multicenter trial.
    Beholz S; Repossini A; Livi U; Schepens M; El Gabry M; Matschke K; Trivedi U; Eckel L; Dapunt O; Zamorano JL
    J Heart Valve Dis; 2010 Jan; 19(1):115-23. PubMed ID: 20329497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early postoperative outcome and hemodynamic performance of the sorin pericarbon stentless aortic valve.
    Bonacchi M; Giunti G; Prifti E; Rostagno C; Bini M; Frati G; Sani G
    J Heart Valve Dis; 2002 Sep; 11(5):703-9. PubMed ID: 12358408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.